首页> 美国卫生研究院文献>Annals of Vascular Diseases >Feasibility of Endovascular Abdominal Aortic Aneurysm Repair Outside of the Instructions for Use and Morphological Changes at 3 Years after the Procedure
【2h】

Feasibility of Endovascular Abdominal Aortic Aneurysm Repair Outside of the Instructions for Use and Morphological Changes at 3 Years after the Procedure

机译:手术后3年使用说明书和形态学改变以外的方法进行血管内腹主动脉瘤修复的可行性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: We retrospectively analyzed outcomes of patients who had undergone endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) more than 3 years previously in a single institution. We compared outcomes between patients who underwent EVAR within and outside of the devices’ instructions for use (IFU) and examined mid-term morphological changes in AAA.Methods: A total of 275 patients who underwent EVAR for AAA were selected. IFU parameters included aneurysmal neck length, angulation and presence of massive atheroma. Patients were divided into 2 groups: the Within IFU group (W-IFU: n = 193) and the Outside of IFU group (O-IFU: n = 82).Results: Patients in the O-IFU group were older and had a larger AAA diameter. Other comorbid factors were similar between the 2 groups. There was no difference in overall survival rates and reintervention rates between the 2 groups. The most common cause for reintervention was AAA enlargement 3 years after EVAR. Irrespective of the IFU, mid-term morphological changes, including neck angulation, neck diameter, sac re-expansion, and Palmaz stent displacement, were found.Conclusion: Outcomes of EVAR were considered acceptable in the O-IFU group. Careful follow-up is necessary considering the morphological changes in AAAs after EVAR.
机译:简介:我们回顾性分析了在单一机构中接受血管内动脉瘤修复(EVAR)的腹主动脉瘤(AAA)超过3年的患者的结局。我们比较了在装置使用说明(IFU)内外接受EVAR的患者的结局,并检查了AAA的中期形态变化。方法:总共选择了275例接受EVAR的患者。 IFU参数包括动脉瘤颈长度,成角度和是否存在大动脉粥样硬化。患者分为2组:IFU组内(W-IFU:n = 193)和IFU组外(O-IFU:n = 82)。更大的AAA直径。两组之间的其他合并症因素相似。两组之间的总生存率和再干预率没有差异。再次介入的最常见原因是EVAR 3年后AAA扩大。不论IFU如何,均发现了中期形态学变化,包括颈部角度,颈部直径,囊重张和Palmaz支架移位。结论:在O-IFU组中,EVAR的结果被认为是可以接受的。考虑到EVAR后AAA的形态变化,需要仔细随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号